Cepheid Files $120M Shelf Registration

genomeweb
360dx

Cepheid Files $120M Shelf Registration

Feb 06, 2006

NEW YORK, Feb. 6 (GenomeWeb News) - Cepheid filed a shelf registration with regulators on Friday to sell up to $120 million in common stock from time to time on terms to be determined at the time of sale.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Oxford Biodynamics Posts Flat Revenues for FY 2018
Exosome Diagnostics Suing Former Employee for IP Theft
Fluidigm Commences $55M Public Stock Offering
BiomX Inks IBD Biomarker Deal With Janssen
InterVenn BioSciences Raises $9.4M in Funding
Centogene Inks Drug Discovery, Development Deal With Chiesi

The Scan

Blame the Follicles

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Missed a Few

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

This Week in Cell

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Main menu